SerRS Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SerRS monoclonal antibodies for investigating Serine-Resistant Synthetase (SerRS) in cellular processes. SerRS monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Serine-Resistant Synthetase is essential for serine synthesis, an amino acid that plays a vital role in protein synthesis, cell signaling, and metabolic pathways. SerRS research has significant implications for understanding various diseases, particularly in cancer and neurodegenerative disorders. Investigating SerRS function can reveal potential therapeutic strategies and molecular mechanisms underlying these conditions. SerRS monoclonal antibodies enable precise detection and analysis of SerRS expression, localization, and interactions within cellular environments. Studying SerRS activity patterns helps researchers understand its role in both normal cellular functions and disease states. SerRS monoclonal antibodies support cutting-edge research that advances scientific understanding of cellular processes and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific knowledge through reliable and specific detection methods that support breakthrough discoveries in the research community.